药物再评价_药药网

名称：名称(英)：

药物再评价19557个记录

药物再评价

id

名称

名称(英)

性别对全身性银屑病治疗的影响：BIOBADADERM 前瞻性队列中处方、有效性和安全性的差异

Effect of Sex in Systemic Psoriasis Therapy: Differences in Prescription, Effectiveness and Safety in the BIOBADADERM Prospective Cohort

与私营医疗保健部门合作以控制印度的结核病：成本和成本效益

Engaging with the private healthcare sector for the control of tuberculosis in India: cost and cost-effectiveness

评估 Cemiplimab 对成人晚期皮肤鳞状细胞癌的价值：成本效益分析

Assessing the Value of Cemiplimab for Adults With Advanced Cutaneous Squamous Cell Carcinoma: A Cost-Effectiveness Analysis

中国2型糖尿病人群达格列净治疗与二甲双胍治疗的成本效益分析

Cost-effectiveness analysis of dapagliflozin treatment versus metformin treatment in Chinese population with type 2 diabetes

对 SARS-CoV-2 复制的全面攻击

An all-out assault on SARS-CoV-2 replication

新型男性避孕药的开发

Development of Novel Male Contraceptives

一线司维拉姆和镧与钙基粘合剂治疗慢性肾脏病高磷血症的成本效益

Cost-Effectiveness of First-Line Sevelamer and Lanthanum versus Calcium-Based Binders for Hyperphosphatemia of Chronic Kidney Disease

米拉贝隆对伴有或不伴有良性前列腺增生的男性膀胱过度活动症患者的安全性和有效性：一项日本上市后研究

Safety and effectiveness of mirabegron in male patients with overactive bladder with or without benign prostatic hyperplasia: A Japanese post-marketing study

韩国治疗心房颤动的心率和节律控制药物的成本效益

Cost-Effectiveness of Rate- and Rhythm-Control Drugs for Treating Atrial Fibrillation in Korea

药物提示反应性涉及分层仪器学习：从双条件巴甫洛夫到仪器迁移任务的证据

Drug cue reactivity involves hierarchical instrumental learning: evidence from a biconditional Pavlovian to instrumental transfer task

Onasemnogene Abeparvovec-xioi (Zolgensma) 和 Nusinersen (Spinraza) 治疗荷兰 I 型脊髓性肌萎缩症复发情况的早期成本效益

Early Cost-Effectiveness of Onasemnogene Abeparvovec-xioi (Zolgensma) and Nusinersen (Spinraza) Treatment for Spinal Muscular Atrophy I in The Netherlands With Relapse Scenarios

生物治疗周期在克罗恩病管理中的成本效益

The Cost-effectiveness of Biological Therapy Cycles in the Management of Crohn's Disease

当前针对 COVID-19 的策略

Current strategies against COVID-19

将印度分枝杆菌疫苗纳入新诊断麻风病例的多药治疗以获得更好的治疗效果和成本效益?接触者的免疫预防作为印度国家麻风病根除计划的麻风病控制措施

Cost-effectiveness of incorporating Mycobacterium indicus pranii vaccine to multidrug therapy in newly diagnosed leprosy cases for better treatment outcomes & immunoprophylaxis in contacts as leprosy control measures for National Leprosy Eradication Programme in India

青少年特发性脊柱侧弯手术静脉注射对乙酰氨基酚和酮咯酸的成本效益

Cost-effectiveness of intravenous acetaminophen and ketorolac in adolescents undergoing idiopathic scoliosis surgery

用于儿童和青少年的第二代抗精神病药物

Second-Generation Antipsychotic Drugs for Children and Adolescents

对通过不同途径给药的止痛和止痒药物的有效性的期望

Expectations about the effectiveness of pain- and itch-relieving medication administered via different routes

0.1%氟轻松治疗口腔黏膜疾病的疗效及副作用综述

A Review of the Effectiveness and Side-Effects of Fluocinolone Acetonide 0.1% in the Treatment of Oral Mucosal Diseases

NIR 介导的药物释放和使用黑色素负载脂质体的肿瘤治疗学

NIR-Mediated drug release and tumor theranostics using melanin-loaded liposomes

雷帕霉素和 AICAR 联合使用可增强减少肾癌的临床前证据

Preclinical evidence of the enhanced effectiveness of combined rapamycin and AICAR in reducing kidney cancer

最新招商产品更多>>

网站地图 - 网站开发 - 网站简介 - 会员服务 - 法律声明 - 联系我们 - 药品招商频道 - 药品信息排行 - 2018年版国家基本药物目录 - 意见反馈

免责声明：以上所展示的信息由企业自行提供，内容的真实性、准确性和合法性由发布企业负责，医药网对此不承担任何责任。
相关链接：国家药品监督管理局| 国家中医药管理局| SDA药品评审中心| 化妆品招商网资讯| 卫生部| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究　　客服热线：0575-83552251 / 13754370441 QQ客服：

浙ICP备16010490号-2 增值电信业务经营许可证：浙B2-20220931　互联网药品信息服务资格证书编号：(浙)-经营性2023-0215　

浙公网安备:330683240604819103159
　医药代理商群１：

药药网医药代理

医药代理商群２：

药药网医药代理2

医药代理商群３：

药药网医药代理3